Patent · US Active

Thiazolopyridinone derivates as MCH receptor antagonists

US7902356B2 · kind B2 · utility

2Cited by

0References

11Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Albert Amegadzie · Moorpark, US
James P. Beck · Zionsville, US
Kevin Matthew Gardinier · Fishers, US
Erik James Hembre · Indianapolis, US
James Craig Ruble · Greenwood, US
Kenneth A. Savin · New York, US
Brian D. Wakefield · Skokie, US

Key dates

Filing date	Dec 16, 2005
Grant date	Mar 8, 2011
Priority date	—
Expiry date	Mar 8, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein w, R1, q, p, R2, t, Ar1, L1, R3 and R4 are as defined, or a pharmaceutically acceptable salt, solvate, or enantiomer thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.